Bright Minds Biosciences, Inc. (DRUG)
66.91
+1.75
(+2.69%)
USD |
NASDAQ |
Sep 08, 16:00
67.50
+0.59
(+0.88%)
Pre-Market: 08:41
Bright Minds Biosciences Total Assets (Quarterly) : 218.74M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 218.74M |
| March 31, 2026 | 223.83M |
| December 31, 2025 | 66.30M |
| September 30, 2025 | 60.67M |
| June 30, 2025 | 38.47M |
| March 31, 2025 | 39.24M |
| December 31, 2024 | 40.61M |
| September 30, 2024 | 4.519M |
| June 30, 2024 | 4.588M |
| March 31, 2024 | 4.826M |
| December 31, 2023 | 5.223M |
| September 30, 2023 | 5.088M |
| Date | Value |
|---|---|
| June 30, 2023 | 6.394M |
| March 31, 2023 | 7.380M |
| December 31, 2022 | 8.524M |
| September 30, 2022 | 8.797M |
| June 30, 2022 | 6.837M |
| March 31, 2022 | 9.418M |
| December 31, 2021 | 12.23M |
| September 30, 2021 | 15.85M |
| June 30, 2021 | 17.97M |
| March 31, 2021 | 20.51M |
| December 31, 2020 | 1.714M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.793M |
| Shareholders Equity (Quarterly) | 216.95M |
| Debt to Equity Ratio | 0.0002 |
| Current Ratio | 121.98 |
| Net Debt Paydown Yield | 0.00% |